Conclusion lessons from the novel D2 dopamine receptor, β2-adrenoceptor agonist, Viozan™: chronic obstructive pulmonary disease and drug development implications

✍ Scribed by P. Calverley; E.T. Keating; M. Goldman; F. Casty

• Book ID: 117647105
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 424 KB
• Volume: 97
• Category: Article
• ISSN: 0954-6111
• DOI: 10.1016/s0954-6111(03)80017-3